Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 9;6(6):e627. doi: 10.1212/NXI.0000000000000627. Print 2019 Nov.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Humans
  • Immunologic Factors / pharmacology*
  • Immunologic Memory*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Leukoencephalopathy, Progressive Multifocal / immunology*
  • Male
  • T-Lymphocyte Subsets*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • pembrolizumab